Home About SPA Join SPA Education / Meetings Newsletter Job Opportunities Volunteer Service Abroad Links of Interest
member button
 

SPA Newsletter

.

Volume 17 Number 3
Summer 2004 Newsletter
spa@societyhq.com

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia

Samuel Charache, MD, et al

This paper is a follow-up of a previous open label study of hydroxyurea therapy in patients with sickle cell anemia which found increased production of fetal hemoglobin in treated patients with evidence of only mild myelotoxicity. This trial, which was blinded and double-blinded 299 adults were assigned to receive either hydroxyurea or placebo. Those in the treatment group had lower annual rates of painful crises. This difference did not begin to emerge until about two months into the study. Fewer patients in the treatment group had acute chest syndrome and received fewer transfusions. Overall there was a 445 reduction in the number of painful crises in the treatment group compared to the placebo group.

There was a four-week period at the start of the study prior to randomization when all patients received folic acid only. Hydroxyurea was begun as 15 mg/kg/day and increased every 12 weeks by 5 mg/kg/day unless evidence of myelosupression was seen the dose was adjusted downward by 2.5 mg/kg/day. During the study 12 patients did not require transfusions. Eleven on these patients were in the treatment group.

In their discussion, the authors point out the possible therapeutic and also deleterious effects of treatment with hydroxyurea. They speculate that the mechanism by which hydroxyurea exerts its therapeutic effect are increased fetal hemoglobin production, increased rbc water, and/or decreased rbc adhesion. The authors point out reports possibly linking long-term use of hydroxyurea to the development of leukemia and the unproved safety of this agent's use in pregnancy. Finally they state that hydroxyurea is useful as a preventative measure for painful crises but it has no role in treatment of crises in progress.


Table of Contents


Newsletter Archive

 

 

 

© 2010 Society for Pediatric Anesthesia
2209 Dickens Road, Richmond, VA 23230-2005 • Phone: 804-282-9780 • Fax: 804-282-0090 • spa@societyhq.com
PRIVACY POLICYREFUND / CANCELLATION POLICY